During the last session, Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s traded shares were 0.17 million, with the beta value of the company hitting 0.85. At the end of the trading day, the stock’s price was $2.36, reflecting an intraday loss of -1.67% or -$0.04. The 52-week high for the PHIO share is $9.79, that puts it down -314.83 from that peak though still a striking 58.9% gain since the share price plummeted to a 52-week low of $0.97. The company’s market capitalization is $11.33M, and the average intraday trading volume over the past 10 days was 1.16 million shares, and the average trade volume was 3.23 million shares over the past three months.

Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information

Phio Pharmaceuticals Corp (PHIO) registered a -1.67% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.67% in intraday trading to $2.36, hitting a weekly high. The stock’s 5-day price performance is -7.45%, and it has moved by 28.96% in 30 days. Based on these gigs, the overall price performance for the year is -63.09%. The short interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 0.23 million shares and it means that shorts have 0.28 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 66.30%. While earnings are projected to return 82.60% in 2025, the next five years will return 64.39% per annum.

PHIO Dividends

Phio Pharmaceuticals Corp is due to release its next quarterly earnings on 2025-Mar-31. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders

Phio Pharmaceuticals Corp insiders own 0.40% of total outstanding shares while institutional holders control 15.77%, with the float percentage being 15.83%.